Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Platelet-rich plasma with a new carrier significantly increases hair thickness without serious side effects.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Choosing the right model order in brain connectivity analysis can affect the detection of differences between healthy individuals and those with seasonal affective disorder.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

Insulin resistance linked to obesity may increase COVID-19 severity.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.